DE69729213D1 - Tricyclische aminderivate - Google Patents

Tricyclische aminderivate

Info

Publication number
DE69729213D1
DE69729213D1 DE69729213T DE69729213T DE69729213D1 DE 69729213 D1 DE69729213 D1 DE 69729213D1 DE 69729213 T DE69729213 T DE 69729213T DE 69729213 T DE69729213 T DE 69729213T DE 69729213 D1 DE69729213 D1 DE 69729213D1
Authority
DE
Germany
Prior art keywords
hydrate
chem
tricyclic amine
salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69729213T
Other languages
English (en)
Other versions
DE69729213T2 (de
Inventor
Makoto Takemura
Hisashi Takahashi
Kenichi Kimura
Rie Miyauchi
Hitoshi Ohki
Katsuhiro Kawakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69729213D1 publication Critical patent/DE69729213D1/de
Publication of DE69729213T2 publication Critical patent/DE69729213T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69729213T 1996-10-25 1997-10-23 Tricyclische aminderivate Expired - Lifetime DE69729213T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP28344696 1996-10-25
JP28344696 1996-10-25
JP9125497 1997-04-10
JP9125497 1997-04-10
PCT/JP1997/003842 WO1998018783A1 (fr) 1996-10-25 1997-10-23 Derives d'amine tricycliques

Publications (2)

Publication Number Publication Date
DE69729213D1 true DE69729213D1 (de) 2004-06-24
DE69729213T2 DE69729213T2 (de) 2005-05-04

Family

ID=26432708

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729213T Expired - Lifetime DE69729213T2 (de) 1996-10-25 1997-10-23 Tricyclische aminderivate

Country Status (12)

Country Link
US (2) US6384050B1 (de)
EP (1) EP0947513B1 (de)
KR (1) KR100531967B1 (de)
CN (1) CN1103769C (de)
AT (1) ATE267191T1 (de)
AU (1) AU4723197A (de)
DE (1) DE69729213T2 (de)
DK (1) DK0947513T3 (de)
ES (1) ES2221040T3 (de)
PT (1) PT947513E (de)
TW (1) TW491849B (de)
WO (1) WO1998018783A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
CN1343128B (zh) 1999-03-17 2010-04-21 第一制药株式会社 药物组合物
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (de) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
AU3089302A (en) 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
JP2004515548A (ja) 2000-12-14 2004-05-27 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en) * 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRPI0709772B8 (pt) 2006-03-28 2021-05-25 The Protecter & Gamble Company sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico
CA2647454A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
EP1849770A1 (de) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Prozess für die Herstellung von bizyklischen Tetrahydropyrrolverbindungen
CN102140098A (zh) * 2010-01-29 2011-08-03 南京医科大学 7-(2-取代-3-氨基-1-四氢吡咯[3,4-c]吡唑基)喹啉羧酸衍生物及其制备方法和在抗菌抗结核上的应用
MA50245A (fr) * 2017-09-11 2020-07-22 Krouzon Pharmaceuticals Inc Inhibiteurs allostériques octahydrocyclopenta[c]pyrrole de shp2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637886A (en) 1982-12-27 1987-01-20 Exxon Research & Engineering Co. Macrocyclic polyamine and polycyclic polyamine multifunctional lubricating oil additives
JPH0676400B2 (ja) 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
RU2049777C1 (ru) 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
CA2112165C (en) * 1992-12-25 2003-04-08 Makoto Takemura Bicyclic amine derivatives
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
AU4723197A (en) 1998-05-22
DK0947513T3 (da) 2004-08-30
TW491849B (en) 2002-06-21
DE69729213T2 (de) 2005-05-04
CN1103769C (zh) 2003-03-26
EP0947513B1 (de) 2004-05-19
EP0947513A1 (de) 1999-10-06
US6384050B1 (en) 2002-05-07
PT947513E (pt) 2004-09-30
CN1242011A (zh) 2000-01-19
WO1998018783A1 (fr) 1998-05-07
ES2221040T3 (es) 2004-12-16
US6586604B2 (en) 2003-07-01
US20010037030A1 (en) 2001-11-01
KR100531967B1 (ko) 2005-11-30
ATE267191T1 (de) 2004-06-15
KR20000052784A (ko) 2000-08-25
EP0947513A4 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
NO950297L (no) Prolinamidderivater
DE69331414T2 (de) Depsipeptide, herstellung und anwendung
PT1319651E (pt) Composto 2-aminopropano-1,3-diol, sua utilizacao farmaceutica e seus intermediarios sinteticos
DK0947513T3 (da) Tricykliske aminderivater
PT718293E (pt) Composto ciclodepsipeptidico
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
MX9206093A (es) Derivado de oxazolidona
ATE126796T1 (de) Quinazolinderivate und ihre herstellung.
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
BR9916466A (pt) Compostos de organofósforo e seu uso
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
MX9206930A (es) Nuevos compuestos
DE69400352T2 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids
PT816355E (pt) Derivados espiro-heterociclicos
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition